# Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray

> **NCT06023368** · PHASE4 · WITHDRAWN · sponsor: **Marianne Hutti**

## Conditions studied

- Pediatric Cancer

## Interventions

- **DRUG:** Num Vapocoolant Spray
- **DRUG:** EMLA Cream

## Key facts

- **NCT ID:** NCT06023368
- **Lead sponsor:** Marianne Hutti
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-12-23
- **Primary completion:** 2024-06-20
- **Final completion:** 2024-06-20
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Administrative burden
- **Last updated:** 2024-11-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06023368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06023368, "Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06023368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*